As of 2025-03-22, the Relative Valuation of Codiak BioSciences, Inc. (CDAK) is (11.96) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.06 USD, the upside of Codiak BioSciences, Inc. based on Relative Valuation is -21076.3%.
The range of the Relative Valuation is (9.50) - (13.65) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.4x - 36.4x | 28.9x |
| Forward P/E multiples | 19.2x - 30.7x | 25.0x |
| Fair Price | (9.50) - (13.65) | (11.96) |
| Upside | -16772.0% - -24048.4% | -21076.3% |
| Date | P/E |